Stride combines DNA, blood and gut health testing with personalised insights to help people understand and proactively manage their health.
Stride has raised €5.5M across 1 funding round from 6 investors, most recently a Seed round in Oct 2026. Based in London, UK; active in Healthtech. Data as of 14 Oct 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-10-14 | Seed | €5.5M |
| a16z Scout Fund,Angel Investors,Arāya Ventures,Better Ventures,Innovate UK,Morgan Stanley Inclusive & Sustainable Ventures |
| View deal → |
